Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Sell
24
CG Quote, Financials, Valuation and Earnings
Last price:
$44.13
Seasonality move
:
7.21%
Day range:
$42.97 - $44.42
52-week range:
$36.65 - $57.50
Dividend yield:
3.17%
P/E ratio:
15.87x
P/S ratio:
4.77x
P/B ratio:
2.84x
Volume:
3.6M
Avg. volume:
3.2M
1-year change:
-6.88%
Market cap:
$15.9B
Revenue:
$3.4B
EPS (TTM):
$2.78
Analysts' Opinion
-
Consensus RatingThe Carlyle Group has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 9 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $56.18, The Carlyle Group has an estimated upside of 27.3% from its current price of $44.13.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $47.00 representing -6.5% downside risk from its current price of $44.13.
Fair Value
-
According to the consensus of 12 analysts, The Carlyle Group has 27.3% upside to fair value with a price target of $56.18 per share.
CG vs. S&P 500
-
Over the past 5 trading days, The Carlyle Group has overperformed the S&P 500 by 3.65% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
The Carlyle Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Carlyle Group has grown year-over-year revenues for 2 quarters straight. In the most recent quarter The Carlyle Group reported revenues of $771.3M.
Earnings Growth
-
The Carlyle Group has grown year-over-year earnings for 1 quarter straight. In the most recent quarter The Carlyle Group reported earnings per share of $0.57.
Enterprise value:
24.1B
EV / Invested capital:
--
Price / LTM sales:
4.77x
EV / EBIT:
11.58x
EV / Revenue:
7.08x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-28.76x
Price / Operating cash flow:
46.49x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
4.64%
Net Income Margin (TTM):
29.99%
Return On Equity:
17.04%
Return On Invested Capital:
6.56%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $3.4B | $1.3B | $3.4B | -$373.7M | $771.3M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $3.36 | -$1.68 | $2.78 | -$1.91 | $0.57 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $3.1B | $2.3B | $2.6B | $3.1B | |
| Total Assets | $15.6B | $21.3B | $21.4B | $21.2B | $23.1B | |
| Current Liabilities | $436.7M | $388.1M | $362.5M | $275.9M | $241.9M | |
| Total Liabilities | $12.7B | $15.5B | $14.6B | $15.4B | $16.8B | |
| Total Equity | $2.9B | $5.7B | $6.8B | $5.8B | $6.3B | |
| Total Debt | $8B | $8.5B | $8.7B | $9.3B | $9.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$379.3M | $204.9M | -$759.5M | $254.1M | -$352.8M | |
| Cash From Investing | -$828.8M | -$43.6M | -$77.6M | $40.9M | -$26.7M | |
| Cash From Financing | $114.8M | -$99.6M | $682.8M | -$152.2M | $312.1M | |
| Free Cash Flow | -$1B | $138.3M | -$837.2M | $237.1M | -$379.5M | |
CG
Sector
Market Cap
$15.9B
$616.2M
Price % of 52-Week High
76.75%
85.86%
Dividend Yield
3.17%
1.99%
Shareholder Yield
5.51%
3.77%
1-Year Price Total Return
-6.88%
8.45%
Beta (5-Year)
1.728
0.714
Dividend yield:
3.17%
Annualized payout:
$1.40
Payout ratio:
49.29%
Growth streak:
3 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$42.77
200-day SMA
Sell
Level
$46.74
Bollinger Bands (100)
Sell
Level
47.3 - 54.58
Chaikin Money Flow
Buy
Level
113.2M
20-day SMA
Sell
Level
$45.40
Relative Strength Index (RSI14)
Sell
Level
44.30
ADX Line
Sell
Level
33.82
Williams %R
Neutral
Level
-42.709
50-day SMA
Sell
Level
$50.25
MACD (12, 26)
Sell
Level
-2.20
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
132.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3642)
Sell
CA Score
(Annual)
Level (-1.158)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.5408)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Carlyle Group is one of the world's largest alternative-asset managers, with $447.4 billion in total AUM, including $313.6 billion in fee-earning AUM, at the end of September 2024. The company has three core business segments: private equity, which includes private equity, real estate, infrastructure, and natural resources funds (accounting for 33% of fee-earning AUM and 57% of base management fees during 2023), global credit (51% and 27%) and investment solutions (16% and 16%). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 2,900 active carry fund investors from 88 countries.
Stock Forecast FAQ
In the current month, CG has received 3 Buy ratings 9 Hold ratings, and 0 Sell ratings. The CG average analyst price target in the past 3 months is $56.18.
-
Where Will The Carlyle Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Carlyle Group share price will rise to $56.18 per share over the next 12 months.
-
What Do Analysts Say About The Carlyle Group?
Analysts are divided on their view about The Carlyle Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Carlyle Group is a Sell and believe this share price will drop from its current level to $47.00.
-
What Is The Carlyle Group's Price Target?
The price target for The Carlyle Group over the next 1-year time period is forecast to be $56.18 according to 12 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is CG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Carlyle Group is a Hold. 9 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CG?
You can purchase shares of The Carlyle Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Carlyle Group shares.
-
What Is The The Carlyle Group Share Price Today?
The Carlyle Group was last trading at $44.13 per share. This represents the most recent stock quote for The Carlyle Group. Yesterday, The Carlyle Group closed at $44.13 per share.
-
How To Buy The Carlyle Group Stock Online?
In order to purchase The Carlyle Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
